Patients with limited prognosis often have co-morbidities requiring the use of anticoagulation, including atrial fibrillation, history of embolic stroke, and venous thromboembolic disease. Several studies have shown that the incidence of thromboembolism in these patients is as high as 50%. At the same time, most of these patients are also at high risk for bleeding complications. To date, there are no consensus guidelines regarding when anticoagulation should be continued or discontinued in patients with limited prognosis. This Fast Fact discusses factors informing the use of anticoagulation in these patients.
Links: Fast Facts #461 (4/2023)